PUBLICATION

Efficacy of Moxifloxacin against Mycobacterium abscessus in Zebrafish Model in vivo

Authors
Nie, W.J., Xie, Z.Y., Gao, S., Teng, T.L., Zhou, W.Q., Shang, Y.Y., Jing, W., Shi, W.H., Wang, Q.F., Huang, X.R., Cai, B.Y., Wang, J., Wang, J., Guo, R., Ge, Q.P., Nie, L.H., Han, X.Q., Du, Y.D., Chu, N.H.
ID
ZDB-PUB-200620-5
Date
2020
Source
Biomedical and environmental sciences : BES   33: 350-358 (Journal)
Registered Authors
Keywords
Azithromycin, Moxifloxacin, Mycobacterium abscessus, Zebrafish
MeSH Terms
  • Animals
  • Anti-Bacterial Agents/pharmacology*
  • Disease Models, Animal
  • Moxifloxacin/pharmacology*
  • Mycobacterium Infections, Nontuberculous/drug therapy*
  • Mycobacterium abscessus/drug effects*
  • Zebrafish*
PubMed
32553079 Full text @ Biomed. Environ. Sci.
Abstract
Moxifloxacin (MFX) shows good in vitro activity against Mycobacterium abscessus and can be a possible antibiotic therapy to treat M. abscessus infection; however, other studies have shown a lower or no activity. We aimed to evaluate MFX activity against M. abscessus using zebrafish (ZF) model in vivo.
A formulation of M. abscessus labeled with CM-Dil was micro-injected into ZF. Survival curves were determined by recording dead ZF every day. ZF were lysed, and colony-forming units (CFUs) were enumerated. Bacteria dissemination and fluorescence intensity in ZF were analyzed. Inhibition rates of MFX and azithromycin (AZM, positive control) were determined and compared.
Significantly increased survival rate was observed with different AZM concentrations. However, increasing MFX concentration did not result in a significant decrease in ZF survival curve. No significant differences in bacterial burdens by CFU loads were observed between AZM and MFX groups at various concentrations. Bacterial fluorescence intensity in ZF was significantly correlated with AZM concentration. However, with increasing MFX concentration, fluorescence intensity decreased slightly when observed under fluorescence microscope. Transferring rates at various concentrations were comparable between the MFX and AZM groups, with no significant difference.
MFX showed limited efficacy against M. abscessusin vivo using ZF model. Its activity in vivo needs to be confirmed.
Genes / Markers
Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping